Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " July 01, 2012":" July 31, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Positive Change Agents Program-Tanzania (Evaluation)
Condition: HIV Infection
Intervention: Behavioral: Appreciative Inquiry Change Agents (CA) program (NAMWEZA)
2 Unknown  BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection
Condition: HIV
Intervention: Drug: efavirenz
3 Unknown  A Couple-Based Relationship Strengthening HIV Intervention for Young Parents
Condition: HIV
Interventions: Behavioral: Relationship Strengthening HIV Prevention Intervention;   Behavioral: Parenting Program Intervention
4 Active, not recruiting Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
Conditions: HIV Infection;   Healthy
Intervention:
5 Completed Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
Conditions: HIV;   HIV Infections;   AIDS;   Antiretroviral Therapy
Interventions: Behavioral: Control;   Behavioral: Intervention
6 Unknown  Enhancing Ugandan HIV-Affected Child Development With Caregiver Training
Condition: HIV
Interventions: Behavioral: MISC;   Behavioral: UCOBAC
7 Recruiting Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi
Condition: HIV
Interventions: Drug: Standard of Care prophylaxis;   Drug: Chloroquine (CQ) prophylaxis
8 Completed Atazavanir/Ritonavir-based HAART in Children
Condition: HIV
Intervention: Drug: boosted atazanavir (ATV/r)
9 Unknown  Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings
Condition: HIV
Interventions: Other: EMR Only;   Other: EMR+CDSS
10 Withdrawn Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
Conditions: HIV;   Hepatitis C
Intervention: Drug: Rifaximin
11 Completed Abacavir and Lamivudine PK in Children
Condition: HIV
Interventions: Drug: abacavir;   Drug: 3TC
12 Completed Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services
Condition: HIV
Intervention: Drug: 1% tenofovir gel
13 Completed Relative Bioavailability Study of GSK1265744 Formulations
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: GSK1265744 Na Salt Tablets;   Drug: GSK1265744 Free Acid Nanomilled Capsules;   Drug: GSK1265744 Free Acid Micronized Capsules
14 Completed Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Condition: HIV
Interventions: Drug: Tenofovir (TFV) Alone Vaginal Tablet;   Drug: Emtricitabine (FTC) Alone Vaginal Tablet;   Drug: TFV and FTC Combined Vaginal Tablet;   Drug: Placebo Vaginal Tablet
15 Enrolling by invitation Bone Health and Vitamin D Status
Conditions: Osteopenia;   Vitamin D Deficiency;   HIV Infection
Intervention:
16 Completed Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
Conditions: Tuberculosis;   HIV
Interventions: Biological: MVA85A;   Biological: Candin;   Biological: BCG Vaccine SSI
17 Completed Violence and HIV Risk Among Women
Condition: HIV Risk Reduction
Interventions: Behavioral: supporting positive and healthy relationships;   Behavioral: community support group
18 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
19 Completed Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM
Conditions: HIV Testing;   Linkage to Care
Intervention:
20 Completed Children With HIV and Asthma (CHIVAS)
Condition: T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment
Intervention: Drug: HAART

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.